Successful switching from eltrombopag to romiplostim in a pediatric patient with refractory chronic ITP.


Herein, we report a successful treatment experience with romiplostim in a child with immune thrombocytopenia (ITP) refractory to eltrombopag. A 9-year-old female developed chronic ITP, which was refractory to standard treatments, including intravenous immunoglobulin, cepharanthine and splenectomy, and she thus became dependent on prednisolone (PSL). At age… (More)
DOI: 10.11406/rinketsu.56.511


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.